RESUMEN
Using electrophysiology, the effect of nicotinic acetylcholine receptor (nAChR) ligands on acetylcholine-induced depolarization in the neurons of Helix lucorum snail was studied. It was found that the α-conotoxin PnIA [R9, L10], a selective antagonist of α7 nAChR, and α-cobratoxin (antagonist of α7 and muscle-type nAChR) suppressed neuronal depolarization. Fluorescence microscopy showed staining of the neurons with fluorescently labeled α-bungarotoxin; this staining was reduced by pretreatment with α-cobratoxin. Induced depolarization was also suppressed by α-conotoxin RgIA, a selective inhibitor of α9 nAChR. In contrast to Lymnaea stagnalis nAChR, which are weakly sensitive to neurotoxin II and α-conotoxin GI, antagonists of muscle-type nAChR, H. lucorum receptors were most effectively inhibited by these antagonists. The results obtained, as well as the previously found sensitivity of the receptors studied in this work to muscarinic receptor ligands, indicate an unusual atypical pharmacological profile of H. lucorum nAChR.
Asunto(s)
Neuronas/metabolismo , Receptores Colinérgicos/metabolismo , Receptor Nicotínico de Acetilcolina alfa 7/metabolismo , Acetilcolina/metabolismo , Animales , Sitios de Unión , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Bungarotoxinas/metabolismo , Caracoles Helix , Ligandos , Microscopía Confocal , Microscopía Fluorescente , Neurotoxinas/metabolismo , Piridinas/farmacología , Transducción de SeñalRESUMEN
Arginine-containing peptides R3, R8, and R16 were obtained by solid-phase peptide synthesis, and their binding to nicotinic acetylcholine receptors (nAChRs) of muscle and neuronal (α7) types was studied by competitive radioligand assay with the use of 125I-α-bungarotoxin. The resulting peptides exhibited a significantly greater binding activity with respect to the muscle-type nAChRs than to the α7 receptor. Thus, we have discovered a new class of nAChR ligands. The affinity of the synthesized oligoarginines for nAChR depended on the number of amino acid residues in the chain. The highest affinity was exhibited by the R16 peptide, which contained 16 arginine residues.
Asunto(s)
Péptidos , Receptor Nicotínico de Acetilcolina alfa 7/química , Animales , Ligandos , Péptidos/síntesis química , Péptidos/química , TorpedoRESUMEN
With the use of surface plasmon resonance (SPR) it was shown that ws-Lynx1, a water-soluble analog of the three-finger membrane-bound protein Lynx1, that modulates the activity of brain nicotinic acetylcholine receptors (nAChRs), interacts with the acetylcholine-binding protein (AChBP) with high affinity, K D = 62 nM. This result agrees with the earlier demonstrated competition of ws-Lynx1 with radioiodinated α-bungarotoxin for binding to AChBP. For the first time it was shown that ws-Lynx1 binds to GLIC, prokaryotic Cys-loop receptor (K D = 1.3 µM). On the contrary, SPR revealed that α-cobratoxin, a three-finger protein from cobra venom, does not bind to GLIC. Obtained results indicate that SPR is a promising method for analysis of topography of ws-Lynx1 binding sites using its mutants and those of AChBP and GLIC.
Asunto(s)
Proteínas Bacterianas/metabolismo , Encéfalo/metabolismo , Proteínas Neurotóxicas de Elápidos/metabolismo , Receptores de Canales Iónicos con Asa de Cisteína Activados por Ligando/metabolismo , Glicoproteínas de Membrana/metabolismo , Receptor Nicotínico de Acetilcolina alfa 7/metabolismo , Animales , Aplysia , Proteínas Bacterianas/química , Sitios de Unión , Línea Celular , Línea Celular Tumoral , Cianobacterias , Receptores de Canales Iónicos con Asa de Cisteína Activados por Ligando/química , Drosophila melanogaster , Venenos Elapídicos/química , Venenos Elapídicos/metabolismo , Elapidae , Escherichia coli , Células HEK293 , Humanos , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/genética , Modelos Moleculares , Estructura Secundaria de Proteína , Resonancia por Plasmón de Superficie , Receptor Nicotínico de Acetilcolina alfa 7/químicaRESUMEN
We studies the receptor-binding specificity of the synthetic peptide HAP (High Affinity Peptide) and its analogues, which are regarded as a model of the orthosteric site nicotinic acetylcholine receptors (nAChR). Using radioligand analysis, electrophysiology tests, and calcium imaging, we assessed the ability of HAP to interact with nAChR antagonists: long α-neurotoxins and α-conotoxins. A high affinity of HAP for α-bungarotoxin and the absence of its interaction with α-cobratoxin and α-conotoxins was found. The synthesized analogues of HAP in general retained the properties of the original peptide. Thus, HAP cannot be a model of a ligand-binding site.
Asunto(s)
Colinérgicos/farmacología , Fragmentos de Péptidos/metabolismo , Receptores Nicotínicos/metabolismo , Animales , Sitios de Unión , Bungarotoxinas/farmacología , Calcio/metabolismo , Línea Celular , Conotoxinas/metabolismo , Conotoxinas/farmacología , Humanos , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Ratones , Modelos Moleculares , Neurotoxinas/metabolismo , Neurotoxinas/farmacología , Oocitos , Técnicas de Placa-Clamp , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/química , Biblioteca de Péptidos , Ensayo de Unión Radioligante , Ratas , Receptores Nicotínicos/química , Receptores Nicotínicos/genética , Torpedo , Imagen de Colorante Sensible al Voltaje , Xenopus laevisRESUMEN
Nonconventional three-finger toxin BMLCL was isolated from B. multicinctus venom, and its interaction with different subtypes of nicotinic acetylcholine receptor (nAChR) was studied. It was found that BMLCL is able to interact with high efficiency with both α7 and muscle type nAChRs.
Asunto(s)
Bungarotoxinas/metabolismo , Bungarotoxinas/farmacología , Colinérgicos/farmacología , Receptores Nicotínicos/metabolismo , Proteínas de Reptiles/metabolismo , Proteínas de Reptiles/farmacología , Acetilcolina/farmacología , Secuencia de Aminoácidos , Animales , Aplysia , Bungarotoxinas/química , Bungarotoxinas/aislamiento & purificación , Bungarus , Colinérgicos/química , Colinérgicos/aislamiento & purificación , Colinérgicos/metabolismo , Proteínas Neurotóxicas de Elápidos/farmacología , Humanos , Lymnaea , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Datos de Secuencia Molecular , Oocitos , Ratas , Proteínas de Reptiles/química , Proteínas de Reptiles/aislamiento & purificación , Homología de Secuencia de Aminoácido , XenopusRESUMEN
Human protein SLURP-1 is an endogenous neuromodulator belonging to the Ly-6/uPAR family and acting on nicotinic acetylcholine receptors. In the present work, the gene of SLURP-1 was expressed in E. coli. The bacterial systems engineered for SLURP-1 expression as fused with thioredoxin and secretion with leader peptide STII failed in the production of milligram quantities of the protein. The SLURP-1 was produced with high-yield in the form of inclusion bodies, and different methods of the protein refolding were tested. Milligram quantities of recombinant SLURP-1 and its (15)N-labeled analog were obtained. The recombinant SLURP-1 competed with (125)I-α-bungarotoxin for binding to muscle-type Torpedo californica nAChR at micromolar concentrations, indicating a partial overlap in the binding sites for SLURP-1 and α-neurotoxins on the receptor surface. NMR study revealed conformational heterogeneity of SLURP-1 in aqueous solution, which was associated with cis-trans isomerization of the Tyr39-Pro40 peptide bond. The two structural forms of the protein have almost equal population in aqueous solution, and exchange process between them takes place with characteristic time of about 4 ms. Almost complete (1)H and (15)N resonance assignment was obtained for both structural forms of SLURP-1. The secondary structure of SLURP-1 involves two antiparallel ß-sheets formed from five ß-strands and closely resembles those of three-finger snake neurotoxins.
Asunto(s)
Antígenos Ly/genética , Antígenos Ly/metabolismo , Receptores Nicotínicos/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/genética , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Secuencia de Aminoácidos , Antígenos Ly/química , Unión Competitiva , Clonación Molecular , Escherichia coli/genética , Humanos , Espectroscopía de Resonancia Magnética , Conformación Molecular , Datos de Secuencia Molecular , Neurotransmisores/metabolismo , Unión Proteica , Pliegue de Proteína , Estructura Secundaria de Proteína , Alineación de Secuencia , Soluciones/química , Activador de Plasminógeno de Tipo Uroquinasa/químicaRESUMEN
Nicotinic acetylcholine receptors (nAChRs) are implicated in the regulation ofintracellular Ca2+-dependent processes in cells both in normal and pathological states, alpha-Conotoxins isolated from Conus snails venom are a valuable tool for the study of pharmacological properties and functional role of nAChRs. In the present study the alpha-conotoxin MII analogue with the additional tyrosine attached to the N terminus (Y0-MII) was prepared. Also we synthesized analogs with the N-terminal glycine residue labeled with the Bolton- Hunter reagent (BH-MII) or fluorestsein isothiocyanate (FITC-MII). Fluorescence microscopy studies of the neuroblastoma SH-SY5Y cells loaded with Ca2+ indicator Fura-2 or with Ca2+ and Na+ indicators Fluo-4 and SBFI were performed to examine effect of MII modification on its ability to inhibit nicotin-induced increases in intracellular free Ca2+ and Na+ concentrations ([Ca2+] and [Na+]i respectively). Monitoring of individual cell [Ca2+]i and [Na+]i signals revealed different kinetics of [Ca2+]i and [Na+]i rise and decay in responses to brief nicotine (Nic) applications (10-30 microM, 3-5 min), which indicates to different mechanisms of Ca2+ and Na+ homeostasis control in SH-SY5Y cells. MII inhibited in concentration-dependent manner the both [Ca2+]i and [Na+]i increase induced by Nic. Additional tyrosine in the Y0-MII or, especially, more sizeable label in FITC-MII significantly reduced the inhibitory effect of MII. Whereas the efficiency of the Ca2+ response inhibition by BH-MII was found to be close to the efficiency of its inhibition by natural alpha-conotoxin MII, radioiodinated derivatives BH-MII can be used in radioligand assay.
Asunto(s)
Señalización del Calcio/efectos de los fármacos , Calcio/metabolismo , Conotoxinas/farmacología , Neuroblastoma/metabolismo , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , Sodio/metabolismo , Línea Celular Tumoral , Humanos , Proteínas de Neoplasias/agonistas , Proteínas de Neoplasias/metabolismo , Neuroblastoma/patología , Receptores Nicotínicos/metabolismoRESUMEN
Lynx1 expresses in the central nervous system and plays important role in a regulation of nicotinic acetylcholine receptors. Successful milligram-quantitive expression of ws-Lynx1 was achieved only in the case of its production in the form of cytoplasm inclusion bodies. Different conditions of ws-Lynx1 refolding for yield optimization were performed. The obtained recombinant protein was characterized by means of mass spectrometry and CD spectroscopy. The binding experiments on the nAChRs from Torpedo californica membranes revealed that ws-Lynxl is biologically active and blocks muscle nAChR with IC50-20-30 microM.
Asunto(s)
Proteínas Ligadas a GPI/biosíntesis , Neurotransmisores/biosíntesis , Receptores Nicotínicos/metabolismo , Proteínas Recombinantes/biosíntesis , Proteínas Adaptadoras Transductoras de Señales , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Bungarotoxinas/antagonistas & inhibidores , Órgano Eléctrico/química , Órgano Eléctrico/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas Ligadas a GPI/química , Proteínas Ligadas a GPI/farmacología , Expresión Génica , Vectores Genéticos , Humanos , Datos de Secuencia Molecular , Neurotransmisores/química , Neurotransmisores/farmacología , Estructura Terciaria de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacología , Solubilidad , TorpedoAsunto(s)
Algoritmos , Conotoxinas/química , Diseño de Fármacos , Antagonistas Nicotínicos/química , Receptor Nicotínico de Acetilcolina alfa 7/química , Acetilcolina/farmacología , Secuencia de Aminoácidos , Animales , Aplysia , Conotoxinas/genética , Relación Dosis-Respuesta a Droga , Humanos , Ligandos , Lymnaea , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Modelos Moleculares , Datos de Secuencia Molecular , Agonistas Nicotínicos/farmacología , Antagonistas Nicotínicos/farmacología , Oocitos , Xenopus laevis , Receptor Nicotínico de Acetilcolina alfa 7/agonistas , Receptor Nicotínico de Acetilcolina alfa 7/antagonistas & inhibidores , Receptor Nicotínico de Acetilcolina alfa 7/metabolismoRESUMEN
The gene for the "weak" toxin of Naja kaouthia venom was expressed in Escherichia coli. "Weak" toxin is a specific inhibitor of nicotine acetylcholine receptor, but mechanisms of interaction of similar neurotoxins with receptors are still unknown. Systems previously elaborated for neurotoxin II from venom of the cobra Naja oxiana were tested for bacterial production of "weak" toxin from N. kaouthia venom. Constructs were designed for cytoplasmic production of N. kaouthia "weak" toxin in the form of a fused polypeptide chain with thioredoxin and for secretion with the leader peptide STII. However, it became possible to obtain "weak" toxin in milligram amounts only within cytoplasmic inclusion bodies. Different approaches for refolding of the toxin were tested, and conditions for optimization of the yield of the target protein during refolding were investigated. The resulting protein was characterized by mass spectrometry and CD and NMR spectroscopy. Experiments on competitive inhibition of (125)I-labeled alpha-bungarotoxin binding to the Torpedo californica electric organ membranes containing the muscle-type nicotine acetylcholine receptor (alpha1(2)beta1gammadelta) showed the presence of biological activity of the recombinant "weak" toxin close to the activity of the natural toxin (IC(50) = 4.3 +/- 0.3 and 3.0 +/- 0.5 microM, respectively). The interaction of the recombinant toxin with alpha7 type human neuronal acetylcholine receptor transfected in the GH(4)C(1) cell line also showed the presence of activity close to that of the natural toxin (IC(50) 31 +/- 5.0 and 14.8 +/- 1.3 microM, respectively). The developed bacterial system for production of N. kaouthia venom "weak" toxin was used to obtain (15)N-labeled analog of the neurotoxin.
Asunto(s)
Bacterias/genética , Bungarotoxinas/genética , Venenos Elapídicos/genética , Cuerpos de Inclusión/genética , Animales , Bacterias/metabolismo , Bungarotoxinas/metabolismo , Clonación Molecular , Disulfuros/química , Venenos Elapídicos/metabolismo , Elapidae/sangre , Vectores Genéticos , Humanos , Cuerpos de Inclusión/química , Conformación ProteicaRESUMEN
A role of nicotinic acetylcholine receptors (nAChR) in the development of Parkinson's disease (PD) has been investigated using two mouse models corresponding to the presymptomatic stage and the early symptomatic stage of PD. Quantitative determination of nAChR in the striatum and substantia nigra (SN) was performed using the radioactive derivatives of epibatidine, ï¡-conotoxin MII, and ï¡-bungarotoxin as ligands. The number of ligand-binding sites changed differently depending on their location in the brain, the stage of the disease and the receptor subtype. Epibatidine binding decreased in the striatum to 66% and 70% at the presymptomatic and early symptomatic stages, respectively, whereas in SN a 160% increase was registered at the presymptomatic stage. The ï¡-conotoxin MII binding on striatal dopaminergic axonal terminals at the presymptomatic stage decreased by 20% and at the symptomatic stage it demonstrated a further decrease. The increase in ï¡-bungarotoxin binding at the presymptomatic stage and a decrease at the early symptomatic stage was observed in the striatum. In SN, the level of ï¡-bungarotoxin binding decreased at the presymptomatic stage and kept constant at the symptomatic stage. The significant decrease in the expression of Chrna4 and Chrna6 genes encoding ï¡4 and ï¡6 nAChR subunits was observed in SN at the early symptomatic stage, while a 13-fold increase in expression of the Chrna7 gene encoding the ï¡7 nAChR subunit was detected at the presymptomatic stage. The data obtained suggest possible involvement of nAChR in compensatory mechanisms at early PD stages.
Asunto(s)
Cuerpo Estriado/metabolismo , Enfermedad de Parkinson Secundaria/genética , Receptores Nicotínicos/genética , Sustancia Negra/metabolismo , Receptor Nicotínico de Acetilcolina alfa 7/genética , Animales , Enfermedades Asintomáticas , Sitios de Unión , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Bungarotoxinas/farmacología , Conotoxinas/farmacología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/fisiopatología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Regulación de la Expresión Génica , Humanos , Ligandos , Ratones , Agonistas Nicotínicos/farmacología , Especificidad de Órganos , Enfermedad de Parkinson Secundaria/metabolismo , Enfermedad de Parkinson Secundaria/fisiopatología , Unión Proteica , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Piridinas/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores Nicotínicos/metabolismo , Transducción de Señal , Sustancia Negra/efectos de los fármacos , Sustancia Negra/fisiopatología , Receptor Nicotínico de Acetilcolina alfa 7/metabolismoRESUMEN
alpha-Conotoxins, peptide neurotoxins from poisonous marine snails of the genus Conus that highly specifically block nicotinic acetylcholine receptors (AChRs) of various types, are reviewed. Preliminarily, the structural organization of AChRs of the muscular and neuronal types, their involvement in physiological processes, and their role in various diseases are briefly discussed. In this connection, the necessity of quantitative determination of AChR subtypes using neurotoxins and other approaches is substantiated. The chemical structure, spatial organization, and specificity of alpha-conotoxins are mainly discussed, taking into consideration the recent results on the ability of alpha-conotoxins to interact with muscular or neuronal hetero- and homooligomeric AChRs exhibiting a high species specificity. Particular emphasis is placed upon a thorough characterization of the surfaces of interaction of alpha-conotoxins with AChRs using synthetic analogues of alpha-conotoxins, mutations in AChRs, and pairwise mutations in both alpha-conotoxins and AChRs. The discovery in 2001 of the acetylcholine-binding protein from the pond snail Lymnaea stagnalis and the determination of its crystalline structure led to rapid progress in understanding the structural organization of ligand-binding domains of AChRs with which alpha-conotoxins also interact. We discuss the interaction of various alpha-conotoxins with acetylcholine-binding proteins, the recently reported X-ray structure of the complex of the acetylcholine-binding protein from Aplysia californica with the alpha-conotoxin analogue PnIA, and the application of this structure to the modeling of complexes of alpha-conotoxins with various AChRs.
Asunto(s)
Conotoxinas/química , Caracol Conus/química , Neurotoxinas/química , Receptores Nicotínicos/efectos de los fármacos , Animales , Conotoxinas/metabolismo , Conotoxinas/farmacología , Ligandos , Modelos Moleculares , Mutación , Neurotoxinas/metabolismo , Neurotoxinas/farmacología , Antagonistas Nicotínicos/química , Antagonistas Nicotínicos/aislamiento & purificación , Antagonistas Nicotínicos/farmacología , Conformación Proteica , Receptores Nicotínicos/metabolismoRESUMEN
Short-chain alpha-neurotoxins from snakes are highly selective antagonists of the muscle-type nicotinic acetylcholine receptors (nAChR). Although their spatial structures are known and abundant information on topology of binding to nAChR is obtained by labeling and mutagenesis studies, the accurate structure of the complex is not yet known. Here, we present a model for a short alpha-neurotoxin, neurotoxin II from Naja oxiana (NTII), bound to Torpedo californica nAChR. It was built by comparative modeling, docking and molecular dynamics using 1H NMR structure of NTII, cross-linking and mutagenesis data, cryoelectron microscopy structure of Torpedo marmorata nAChR [Unwin, N., 2005. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J. Mol. Biol. 346, 967-989] and X-ray structures of acetylcholine-binding protein (AChBP) with agonists [Celie, P.H., van Rossum-Fikkert, S.E., van Dijk, W.J., Brejc, K., Smit, A.B., Sixma, T.K., 2004. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 (6), 907-914] and antagonists: alpha-cobratoxin, a long-chain alpha-neurotoxin [Bourne, Y., Talley, T.T., Hansen, S.B., Taylor, P., Marchot, P., 2005. Crystal structure of Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors. EMBO J. 24 (8), 1512-1522] and alpha-conotoxin [Celie, P.H., Kasheverov, I.E., Mordvintsev, D.Y., Hogg, R.C., van Nierop, P., van Elk, R., van Rossum-Fikkert, S.E., Zhmak, M.N., Bertrand, D., Tsetlin, V., Sixma, T.K., Smit, A.B., 2005. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat. Struct. Mol. Biol. 12 (7), 582-588]. In complex with the receptor, NTII was located at about 30 A from the membrane surface, the tip of its loop II plunges into the ligand-binding pocket between the alpha/gamma or alpha/delta nAChR subunits, while the loops I and III contact nAChR by their tips only in a 'surface-touch' manner. The toxin structure undergoes some changes during the final complex formation (for 1.45 rmsd in 15-25 ps according to AMBER'99 molecular dynamics simulation), which correlates with NMR data. The data on the mobility and accessibility of spin- and fluorescence labels in free and bound NTII were used in MD simulations. The binding process is dependent on spontaneous outward movement of the C-loop earlier found in the AChBP complexes with alpha-cobratoxin and alpha-conotoxin. Among common features in binding of short- and long alpha-neurotoxins is the rearrangement of aromatic residues in the binding pocket not observed for alpha-conotoxin binding. Being in general very similar, the binding modes of short- and long alpha-neurotoxins differ in the ways of loop II entry into nAChR.
Asunto(s)
Neurotoxinas/metabolismo , Receptores Nicotínicos/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Microscopía por Crioelectrón , Modelos Moleculares , Datos de Secuencia Molecular , Neurotoxinas/química , Resonancia Magnética Nuclear Biomolecular , Homología de Secuencia de Aminoácido , TorpedoRESUMEN
Diversity of nicotinic acetylcholine receptors (nAChRs) mediating Cl- current in voltage-clamped identifiable Lymnaea stagnalis neurons was studied using acetylcholine (ACh), three agonists and alpha-conotoxin ImI (ImI). Cytisine, nicotine, and choline, full agonists at alpha7 subunit-containing nAChRs of vertebrates, were found to evoke at saturating concentration 84-92% of the maximal current elicited by ACh. ImI, known to block selectively alpha7 and alpha9 nAChRs, markedly diminished the responses to ACh. The average maximal ImI-induced block was 80%, leaving a residual current which had very slow kinetics. The choline-, cytisine-, and nicotine-induced currents were blocked by ImI almost completely, suggesting that they activate only ImI-sensitive receptors. Two groups of cells which differ in desensitization kinetics and in sensitivity to ImI were revealed. IC50 values for ImI against ACh were 10.3 and 288 nM, respectively, with the rapidly desensitizing current being the more sensitive to ImI. The data obtained suggest the existence of at least three pharmacologically distinct subtypes of nicotinic receptors in Lymnaea neurons. Two of the subtypes are similar to alpha7 nAChRs of vertebrates, but differ from each other in their affinity for ImI and in their desensitization kinetics. The third subtype is quite distinct, in that it is resistant to ImI, is not activated by nicotine, cytisine or choline, and mediates a very slowly developing current.
Asunto(s)
Canales de Cloruro/fisiología , Lymnaea/fisiología , Agonistas Nicotínicos/farmacología , Antagonistas Nicotínicos/farmacología , Receptores Nicotínicos/fisiología , Animales , Relación Dosis-Respuesta a Droga , Lymnaea/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/fisiologíaRESUMEN
alpha-Bungarotoxin (alpha Bgt) was shown to inhibit the binding of the 125I-labeled substance P (SP) and eledoisin (EL) to the rat brain membranes with Kl values of 8.0 +/- 5.0 x 10(-8) and 1.1 +/- 0.5 x 10(-6) M, respectively. Lower inhibitory activity was manifested by several other postsynaptically acting snake venom neurotoxins. The alpha Bgt inhibition of SP binding with a Kl value of 8.5 +/- 5.5 x 10(-8) M to solubilized preparations of the rat brain membranes was demonstrated. The capacity to displace SP was found for d-tubocurarine and phencyclidine, although at concentrations considerably higher than those affecting the nicotinic acetylcholine receptors (AChRs). The results obtained suggest that some of the alpha Bgt-binding polypeptides, distinct from neuronal AChRs, may be functionally associated with the tachykinin receptors (TchR).
Asunto(s)
Encéfalo/metabolismo , Bungarotoxinas/farmacología , Receptores de Neurotransmisores/metabolismo , Animales , Sitios de Unión/efectos de los fármacos , Eledoisina/metabolismo , Ratas , Receptores de Taquicininas , Solubilidad , Sustancia P/metabolismoRESUMEN
Ion-exchange HPLC is used for purification of the snake venom alpha-neurotoxins, chi-bungarotoxin, cytotoxins, and phospholipases A2. Among these purified polypeptides, phospholipases A2 are found to be the most potent in inhibiting the substance P binding to rat brain membranes, Ki approximately 10(-8) M. Other toxins are weak inhibitors (Ki greater than or equal to 10(-4)-10(-5) M), earlier data on the inhibiting activity of alpha-bungarotoxin being caused by the commercial preparations' contamination with phospholipase A2.
Asunto(s)
Encéfalo/metabolismo , Venenos de Serpiente/química , Sustancia P/metabolismo , Animales , Bungarotoxinas/aislamiento & purificación , Membrana Celular/metabolismo , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico , Citotoxinas/aislamiento & purificación , Neurotoxinas/aislamiento & purificación , Fosfolipasas A/aislamiento & purificación , Fosfolipasas A2 , RatasRESUMEN
The review is devoted to the competitive blockers of different nicotinic acetylcholine receptors, alpha-neurotoxins from snake venoms, and alpha-conotoxins from marine snails of the Conidae family. The relationship between the structure and function of these toxins is discussed. Recent data on the mechanism of alpha-neurotoxin and alpha-conotoxin interaction with the nicotinic acetylcholine receptor are presented.
Asunto(s)
Conotoxinas/farmacología , Neurotoxinas/farmacología , Antagonistas Nicotínicos/farmacología , Secuencia de Aminoácidos , Conotoxinas/química , Modelos Moleculares , Datos de Secuencia Molecular , Neurotoxinas/química , Antagonistas Nicotínicos/química , Homología de Secuencia de AminoácidoRESUMEN
Antagonists of the tachykinin receptors, which have been most widely used in scientific investigations during the past decade (up to 1995 inclusive), are reviewed. The structures and peculiar characteristics of peptide and nonpeptide compounds of this class are described. Applications of these antagonists in the search for new subtypes of tachykinin receptors and for structure-function studies are discussed.
Asunto(s)
Receptores de Taquicininas/antagonistas & inhibidores , Animales , Sitios de Unión , Humanos , Péptidos/química , Péptidos/farmacología , Relación Estructura-ActividadRESUMEN
Two photoactivatable analogues of alpha-conotoxin GI with the benzoylphenylalanine residue (Bpa) substituted for His10 or Tyr11 were synthesized using the method of solid-phase peptide synthesis. In addition, alpha-conotoxin MI was chemically modified by placing an azidobenzoyl or a benzoylbenzoyl photo label at N alpha of Gly1 or N epsilon of Lys10. All the photoactivatable analogues were purified by HPLC, their structures were confirmed by MALDI MS, and the label positions in their molecules were localized by MS of their trypsinolysis fragments. All the analogues interacted with the nicotinic acetylcholine receptor (AChR) from Torpedo californica as efficiently as the native alpha-conotoxins, with the differences in the inhibition constants being within one order of magnitude under the same conditions. [125I]Derivatives prepared from all the analogues retained the ability to be bound by AChR and were used in the photoinduced AChR cross-linking. All the AChR subunits were found to be cross-linked to the photoactivatable analogues, with the linking depending on both the chemical nature of label and its position in the alpha-conotoxin molecule.
Asunto(s)
Conotoxinas/química , Receptores Nicotínicos/metabolismo , Animales , Bioquímica/métodos , Membrana Celular/metabolismo , Conotoxinas/metabolismo , Conotoxinas/farmacología , Glicina/química , Hidrólisis , Concentración 50 Inhibidora , Radioisótopos de Yodo , Lisina/química , Etiquetas de Fotoafinidad/química , Fotoquímica , Relación Estructura-Actividad , TorpedoRESUMEN
alpha-Bungarotoxin was found to inhibit effectively the binding of 125I-labelled substance P and eledoisin to membrane and to solubilize preparations of the rat brain. Other postsynaptic neurotoxins exerted similar but less pronounced influence on the interaction of tachykinins with their receptors. The obtained results suggest that some alpha-bungarotoxin-binding polypeptides in brain are components of tachykinin receptors.